Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer’s disease: the Altoida large cohort study
Abstract Conventional neuropsychological assessments for Alzheimer’s disease are burdensome and inaccurate at detecting mild cognitive impairment and predicting Alzheimer’s disease risk. Altoida’s Digital Neuro Signature (DNS), a longitudinal cognitive test consisting of two active digital biomarker...
Guardado en:
Autores principales: | Irene B. Meier, Max Buegler, Robbert Harms, Azizi Seixas, Arzu Çöltekin, Ioannis Tarnanas |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8ad6563ddcef480eb7e920b165677cf6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Deep-learning-based synthesis of post-contrast T1-weighted MRI for tumour response assessment in neuro-oncology: a multicentre, retrospective cohort study
por: Chandrakanth Jayachandran Preetha, MSc, et al.
Publicado: (2021) -
Influence of MRI on Diagnostic Efficacy and Satisfaction of Patients with Alzheimer’s Disease
por: Zheng Dong, et al.
Publicado: (2021) -
Scoping review: the empowerment of Alzheimer’s Disease caregivers with mHealth applications
por: Eunhee Kim, et al.
Publicado: (2021) -
The effects of seasons and weather on sleep patterns measured through longitudinal multimodal sensing
por: Stephen M. Mattingly, et al.
Publicado: (2021) -
Towards computationally efficient prediction of molecular signatures from routine histology images
por: Maxime W Lafarge, et al.
Publicado: (2021)